CHALLENGES AND OPPORTUNITIES IN VALUE ASSESSMENT OF INNOVATIVE BIOLOGIC MEDICINES

Author(s)

Jinxi Ding, PhD, Professor and Vice Dean, , School of International Pharmaceutical Business, , China Pharmaceutical University, Nanjing, China; Marty Jovic,, MS , Partner, PricewaterhouseCoopers Consulting (Australia) Pty Limited, Barangaroo, Australia

Presentation Documents

The theme of the symposium will focus on value assessment of innovative biologic medicines, particularly to discuss how the value of innovative biologic medicines should be appropriately assessed from clinical, economic and humanistic perspective.

Conference/Value in Health Info

2018-09, ISPOR Asia Pacific 2018, Tokyo, Japan

Code

S8

Topic

Economic Evaluation, Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×